ICSI and PGT-A in PCOS phenotype-D patients: a matched case-control study versus idiopathic infertile women.

Autor: Vaiarelli A; IVIRMA Global Research Alliance, Genera, Clinica Valle Giulia, Via G. De Notaris 2B, Rome, Italy. alberto.vaiarelli@gmail.com., Cimadomo D; IVIRMA Global Research Alliance, Genera, Clinica Valle Giulia, Via G. De Notaris 2B, Rome, Italy., Rucci C; Department of Surgical Sciences, Gynecologic Unit, University of Rome Tor Vergata, Rome, Italy., Innocenti F; IVIRMA Global Research Alliance, Genera, Clinica Valle Giulia, Via G. De Notaris 2B, Rome, Italy., Taggi M; IVIRMA Global Research Alliance, Genera, Clinica Valle Giulia, Via G. De Notaris 2B, Rome, Italy., Pittana E; IVIRMA Global Research Alliance, Genera, Clinica Valle Giulia, Via G. De Notaris 2B, Rome, Italy.; Department of Surgical Sciences, Gynecologic Unit, University of Rome Tor Vergata, Rome, Italy., Fiorentino G; Department of Biology and Biotechnology 'Lazzaro Spallanzani', Laboratory of Biology and Biotechnology of Reproduction, University of Pavia, Pavia, Italy., Petrone P; Department of Surgical Sciences, Gynecologic Unit, University of Rome Tor Vergata, Rome, Italy., Soscia DM; IVIRMA Global Research Alliance, Genera, Clinica Valle Giulia, Via G. De Notaris 2B, Rome, Italy.; Department of Biomedicine and Prevention, University Tor Vergata, Rome, Italy., Fabozzi G; IVIRMA Global Research Alliance, Genera, Clinica Valle Giulia, Via G. De Notaris 2B, Rome, Italy.; IVIRMA Global Research Alliance, B-Woman, Rome, Italy.; Department of Biomedicine and Prevention, University Tor Vergata, Rome, Italy., Mazzilli R; IVIRMA Global Research Alliance, Genera, Clinica Valle Giulia, Via G. De Notaris 2B, Rome, Italy.; Department of Clinical and Molecular Medicine, University 'Sapienza' of Rome, Rome, Italy., Rienzi L; IVIRMA Global Research Alliance, Genera, Clinica Valle Giulia, Via G. De Notaris 2B, Rome, Italy.; Dipartimento Di Scienze Biomolecolari, Università Di Urbino 'Carlo Bo', Urbino, Italia., Ubaldi FM; IVIRMA Global Research Alliance, Genera, Clinica Valle Giulia, Via G. De Notaris 2B, Rome, Italy., Nappi RE; Department of Clinical, Surgical, Diagnostic and Pediatric Sciences, University of Pavia, Pavia, Italy.; Research Center for Reproductive Medicine, Gynecological Endocrinology and Menopause, I.R.C.C.S. Matteo Foundation, Pavia, Italy., Gennarelli G; IVIRMA Global Research Alliance, Livet, Turin, Italy.; Gynecology and Obstetrics 2U, Department of Surgical Sciences, S. Anna Hospital, University of Turin, Turin, Italy.

Publikováno v: Journal of assisted reproduction and genetics [J Assist Reprod Genet] 2024 Nov 04. Date of Electronic Publication: 2024 Nov 04.

Administration of anti-HIV-1 broadly neutralizing monoclonal antibodies with increased affinity to Fcγ receptors during acute SHIV AD8-EO infection.

Autor: Dias J; Immunology Laboratory, Vaccine Research Center, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD, USA., Fabozzi G; Tissue Analysis Core, Vaccine Research Center, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD, USA., Fourati S; Pathology Advanced Translational Research Unit, Department of Pathology and Laboratory Medicine, School of Medicine, Emory University, Atlanta, GA, USA., Chen X; Virology Laboratory, Vaccine Research Center, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD, USA., Liu C; Virology Laboratory, Vaccine Research Center, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD, USA., Ambrozak DR; Immunology Laboratory, Vaccine Research Center, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD, USA., Ransier A; Human Immunology Section, Vaccine Research Center, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD, USA., Laboune F; Human Immunology Section, Vaccine Research Center, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD, USA., Hu J; Human Immunology Section, Vaccine Research Center, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD, USA., Shi W; Virology Laboratory, Vaccine Research Center, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD, USA., March K; Tissue Analysis Core, Vaccine Research Center, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD, USA., Maximova AA; Virology Laboratory, Vaccine Research Center, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD, USA., Schmidt SD; Humoral Immunology Section, Vaccine Research Center, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD, USA., Samsel J; Immunology Laboratory, Vaccine Research Center, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD, USA.; Institute for Biomedical Sciences, George Washington University, Washington, D.C., USA., Talana CA; Virology Laboratory, Vaccine Research Center, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD, USA., Ernste K; Virology Laboratory, Vaccine Research Center, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD, USA., Ko SH; Virus Persistence and Dynamics Section, Vaccine Research Center, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD, USA., Lucas ME; Virus Persistence and Dynamics Section, Vaccine Research Center, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD, USA., Radecki PE; Virus Persistence and Dynamics Section, Vaccine Research Center, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD, USA., Boswell KL; Immunology Laboratory, Vaccine Research Center, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD, USA., Nishimura Y; Laboratory of Molecular Microbiology, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD, USA., Todd JP; Translational Research Program, Vaccine Research Center, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD, USA., Martin MA; Laboratory of Molecular Microbiology, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD, USA., Petrovas C; Tissue Analysis Core, Vaccine Research Center, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD, USA., Boritz EA; Virus Persistence and Dynamics Section, Vaccine Research Center, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD, USA., Doria-Rose NA; Humoral Immunology Section, Vaccine Research Center, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD, USA., Douek DC; Human Immunology Section, Vaccine Research Center, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD, USA., Sékaly RP; Pathology Advanced Translational Research Unit, Department of Pathology and Laboratory Medicine, School of Medicine, Emory University, Atlanta, GA, USA., Lifson JD; AIDS and Cancer Virus Program, Frederick National Laboratory for Cancer Research, Frederick, MD, USA., Asokan M; Virology Laboratory, Vaccine Research Center, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD, USA., Gama L; Immunology Laboratory, Vaccine Research Center, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD, USA., Mascola JR; ModeX Therapeutics, Weston, MA, USA., Pegu A; Virology Laboratory, Vaccine Research Center, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD, USA., Koup RA; Immunology Laboratory, Vaccine Research Center, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD, USA. rkoup@mail.nih.gov.

Publikováno v: Nature communications [Nat Commun] 2024 Aug 29; Vol. 15 (1), pp. 7461. Date of Electronic Publication: 2024 Aug 29.

Association between oocyte donors' or recipients' body mass index and clinical outcomes after first single blastocyst transfers-the uterus is the most affected.

Autor: Fabozzi G; IVIRMA Global Research Alliance, GENERA, Clinica Valle Giulia, Rome, Italy; IVIRMA Global Research Alliance, B-WOMAN, Rome, Italy; Department of Biomedicine and Prevention, University of Rome, Tor Vergata, Rome, Italy., Cimadomo D; IVIRMA Global Research Alliance, GENERA, Clinica Valle Giulia, Rome, Italy. Electronic address: cimadomo@generapma.it., Maggiulli R; IVIRMA Global Research Alliance, GENERA, Clinica Valle Giulia, Rome, Italy., Vaiarelli A; IVIRMA Global Research Alliance, GENERA, Clinica Valle Giulia, Rome, Italy., Badajoz V; IVIRMA Global Research Alliance, GINEFIV, Madrid, Spain., Aura M; IVIRMA Global Research Alliance, GINEFIV, Barcelona, Spain., Canosa S; IVIRMA Global Research Alliance, LIVET, Turin, Italy., Bongioanni F; IVIRMA Global Research Alliance, LIVET, Turin, Italy., Benini F; IVIRMA Global Research Alliance, DEMETRA, Florence, Italy., Livi C; IVIRMA Global Research Alliance, DEMETRA, Florence, Italy., Zacà C; IVIRMA Global Research Alliance, 9.baby, Bologna, Italy., Borini A; IVIRMA Global Research Alliance, 9.baby, Bologna, Italy., Alviggi E; IVIRMA Global Research Alliance, GENERA, Clinica Ruesch, Naples, Italy., Iussig B; IVIRMA Global Research Alliance, GENERA, GENERA Veneto, Marostica, Italy., Hebles M; IVIRMA Global Research Alliance, GINEMED, Sevilla, Spain., Sànchez P; IVIRMA Global Research Alliance, GINEMED, Sevilla, Spain., Cimadomo V; Bank of New York Mellon, Wroclaw, Poland., Rienzi L; IVIRMA Global Research Alliance, GENERA, Clinica Valle Giulia, Rome, Italy; Department of Biomolecular Sciences, the University of Urbino 'Carlo Bo', Urbino, Italy., Llàcer J; IVIRMA Global Research Alliance, GINEFIV, Madrid, Spain.

Publikováno v: Fertility and sterility [Fertil Steril] 2024 Feb; Vol. 121 (2), pp. 281-290. Date of Electronic Publication: 2023 Aug 05.

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Cryostorage management of reproductive cells and tissues in ART: status, needs, opportunities and potential new challenges.

Autor: Canosa S; IVIRMA Global Research Alliance, LIVET, Turin, Italy., Maggiulli R; IVIRMA Global Research Alliance, Clinica Valle Giulia, Rome, Italy., Cimadomo D; IVIRMA Global Research Alliance, Clinica Valle Giulia, Rome, Italy., Innocenti F; IVIRMA Global Research Alliance, Clinica Valle Giulia, Rome, Italy., Fabozzi G; IVIRMA Global Research Alliance, Clinica Valle Giulia, Rome, Italy., Gennarelli G; IVIRMA Global Research Alliance, LIVET, Turin, Italy., Revelli A; IVIRMA Global Research Alliance, LIVET, Turin, Italy., Bongioanni F; IVIRMA Global Research Alliance, LIVET, Turin, Italy., Vaiarelli A; IVIRMA Global Research Alliance, Clinica Valle Giulia, Rome, Italy., Ubaldi FM; IVIRMA Global Research Alliance, Clinica Valle Giulia, Rome, Italy., Rienzi L; IVIRMA Global Research Alliance, Clinica Valle Giulia, Rome, Italy; Department of Biomolecular Sciences, University of Urbino 'Carlo Bo', Urbino, Italy., Palmer GA; International IVF Initiative Inc, New York, NY, USA; Institute of Life, IASO Hospital, Athens, Greece; IVF 2.0 Ltd, London, UK., Nijs M; CooperSurgical, Ballerup, Denmark.. Electronic address: Martine.Nijs@coopersurgical.com.

Publikováno v: Reproductive biomedicine online [Reprod Biomed Online] 2023 Sep; Vol. 47 (3), pp. 103252. Date of Electronic Publication: 2023 Jun 22.